BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8975970)

  • 1. Weight of resected liver is positively correlated with serum hHGF level.
    Miyata K; Taniguchi H; Takeuchi K; Koyama H; Tanaka H; Takahashi T
    Hepatogastroenterology; 1996; 43(12):1589-93. PubMed ID: 8975970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of human hepatocyte growth factor (hHGF) in peritoneal fluid after partial hepatectomy.
    Miyata K; Taniguchi H; Tsubouchi H; Daikuhara Y; Takahashi T
    Hepatogastroenterology; 1996; 43(12):1594-600. PubMed ID: 8975971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of serum hepatocyte growth factor levels in liver diseases.
    Hioki O; Watanabe A; Minemura M; Tsuchida T
    J Med; 1993; 24(1):35-46. PubMed ID: 7684768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preoperative and postoperative variations of human hepatocyte growth factor (hHGF) in hepatectomized patients].
    Ogasawara K; Hata Y; Une Y; Sasaki F; Nakajima Y; Uchino J; Ito Y; Kawai T
    Nihon Geka Gakkai Zasshi; 1994 Aug; 95(8):521-7. PubMed ID: 7969019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in serum human hepatocyte growth factor levels after transcatheter arterial embolization and partial hepatectomy.
    Kaneko A; Hayashi N; Tanaka Y; Ito T; Kasahara A; Kubo M; Mukuda T; Fusamoto H; Kamada T
    Am J Gastroenterol; 1992 Aug; 87(8):1014-7. PubMed ID: 1322635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration in levels of human hepatocyte growth factor following hepatectomy.
    Nishizaki T; Takenaka K; Yoshizumi T; Yanaga K; Soejima Y; Shirabe K; Sugimachi K
    J Am Coll Surg; 1995 Jul; 181(1):6-10. PubMed ID: 7599773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal serum human hepatocyte growth factor levels after partial hepatectomy.
    Higaki I; Yamazaki O; Matsuyama M; Horii K; Kawai S; Hirohashi K; Kinoshita H
    Hepatogastroenterology; 1999; 46(26):1078-82. PubMed ID: 10370670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarification of risk factors for hepatectomy in patients with hepatocellular carcinoma.
    Ishikawa M; Yogita S; Miyake H; Fukuda Y; Harada M; Wada D; Tashiro S
    Hepatogastroenterology; 2002; 49(48):1625-31. PubMed ID: 12397750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum interleukin-6 and hepatocyte growth factor levels in patients after hepatectomy.
    Chijiiwa K; Saiki S; Tanaka M
    Hepatogastroenterology; 2002; 49(44):467-71. PubMed ID: 11995475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
    Wu F; Wu L; Zheng S; Ding W; Teng L; Wang Z; Ma Z; Zhao W
    Dig Liver Dis; 2006 Jul; 38(7):490-7. PubMed ID: 16627020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between human hepatocyte growth factor and interleukin-6 concentrations after surgery.
    Kimura F; Miyazaki M; Suwa T; Kadoyama C; Itoh H; Ambiru S; Shimizu H; Nakagawa K
    Hepatogastroenterology; 1999; 46(26):1030-5. PubMed ID: 10370662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum transforming growth factor-alpha level can be a parameter for evaluating liver regeneration after partial hepatectomy in patients with liver cancer.
    Tomiya T; Hayashi S; Yanase M; Umeda N; Tani M; Yamada S; Masaki N; Ogata I; Fujiwara K
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-14-S6-17. PubMed ID: 9151911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of a protease inhibitor against hepatectomy.
    Gotohda N; Iwagaki H; Ozaki M; Konishi M; Nakagohri T; Takahashi S; Yagi T; Kinoshita T; Tanaka N
    Hepatogastroenterology; 2006; 53(67):115-9. PubMed ID: 16506388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum hepatocyte growth factor before and after resection for hepatocellular carcinoma.
    Hu RH; Lee PH; Yu SC; Sheu JC; Lai MY
    Hepatogastroenterology; 1999; 46(27):1842-7. PubMed ID: 10430357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of human hepatocyte growth factor on the proliferation of human hepatocytes and hepatocellular carcinoma cell lines.
    Efimova EA; Glanemann M; Liu L; Schumacher G; Settmacher U; Jonas S; Langrehr JM; Neuhaus P; Nüssler AK
    Eur Surg Res; 2004; 36(5):300-7. PubMed ID: 15359093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection.
    Chau GY; Lui WY; Chi CW; Chau YP; Li AF; Kao HL; Wu CW
    Eur J Surg Oncol; 2008 Mar; 34(3):333-8. PubMed ID: 17218078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum human hepatocyte growth factor (hHGF) is elevated in patients with metastatic gastric carcinoma.
    Niki M; Isozaki H; Toyoda M; Ishibashi T; Fujii K; Nomura E; Mabuchi H; Nakamura M; Nishiguchi K; Tanigawa N
    Hepatogastroenterology; 1999; 46(25):568-73. PubMed ID: 10228863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental and clinical studies on blood coagulation and lysis system after hepatic resection (author's transl)].
    Saito I
    Hokkaido Igaku Zasshi; 1979 Jul; 54(4):401-15. PubMed ID: 231002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum hyaluronate level for predicting subclinical liver dysfunction after hepatectomy.
    Mizuguchi T; Katsuramaki T; Nobuoka T; Kawamoto M; Oshima H; Kawasaki H; Kikuchi H; Shibata C; Hirata K
    World J Surg; 2004 Oct; 28(10):971-6. PubMed ID: 15573250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.